|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 149.52 USD | -1.31% |
|
+1.66% | +4.31% |
| 17/07 | Consumer Staple Companies Likely Saw Another 'Tricky' Quarter, UBS Says | MT |
| 16/07 | JPMorgan Adjusts Price Target on Procter & Gamble to $162 From $164, Maintains Overweight Rating | MT |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 330,340 | 344,995 | 357,647 | 389,234 | 373,532 | 352,783 | - | - |
| Change | - | 4.44% | 3.67% | 8.83% | -4.03% | -5.55% | - | - |
| Enterprise Value (EV) 1 | 352,040 | 369,274 | 384,008 | 412,212 | 398,484 | 377,082 | 376,884 | 376,268 |
| Change | - | 4.9% | 3.99% | 7.34% | -3.33% | -5.37% | -0.05% | -0.16% |
| P/E | 24.5x | 24.7x | 25.7x | 27.4x | 24.5x | 22.3x | 21.7x | 20.3x |
| PBR | 7.03x | 7.35x | 7.66x | 8.06x | 7.48x | 6.6x | 6.19x | 6.21x |
| PEG | - | 4.38x | 16.59x | 13.47x | 3.01x | 5.21x | 7.34x | 2.95x |
| Capitalization / Revenue | 4.34x | 4.3x | 4.36x | 4.63x | 4.43x | 4.05x | 3.95x | 3.82x |
| EV / Revenue | 4.62x | 4.61x | 4.68x | 4.91x | 4.73x | 4.33x | 4.22x | 4.07x |
| EV / EBITDA | 17x | 17.9x | 18.4x | 18x | 17.1x | 15.9x | 15.4x | 14.6x |
| EV / EBIT | 19.6x | 20.7x | 21.2x | 20.6x | 19.5x | 18.3x | 17.9x | 17x |
| EV / FCF | 22.6x | 27.2x | 27.9x | 24.9x | 27.3x | 25.2x | 24.7x | 22.5x |
| FCF Yield | 4.43% | 3.67% | 3.59% | 4.01% | 3.67% | 3.96% | 4.06% | 4.44% |
| Dividend per Share 2 | 3.242 | 3.523 | 3.681 | 3.829 | 4.076 | 4.265 | 4.458 | 4.663 |
| Rate of return | 2.4% | 2.45% | 2.43% | 2.32% | 2.56% | 2.82% | 2.94% | 3.08% |
| EPS 2 | 5.5 | 5.81 | 5.9 | 6.02 | 6.51 | 6.789 | 6.989 | 7.47 |
| Distribution rate | 58.9% | 60.6% | 62.4% | 63.6% | 62.6% | 62.8% | 63.8% | 62.4% |
| Net sales 1 | 76,118 | 80,187 | 82,006 | 84,039 | 84,284 | 87,103 | 89,413 | 92,412 |
| EBITDA 1 | 20,721 | 20,620 | 20,848 | 22,884 | 23,303 | 23,771 | 24,406 | 25,692 |
| EBIT 1 | 17,986 | 17,813 | 18,134 | 19,988 | 20,456 | 20,574 | 21,067 | 22,191 |
| Net income 1 | 14,306 | 14,742 | 14,653 | 14,879 | 15,974 | 16,437 | 16,950 | 17,857 |
| Net Debt 1 | 21,700 | 24,279 | 26,361 | 22,978 | 24,952 | 24,299 | 24,101 | 23,485 |
| Reference price 2 | 134.93 | 143.79 | 151.74 | 164.92 | 159.32 | 151.50 | 151.50 | 151.50 |
| Nbr of stocks (in thousands) | 2,448,233 | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | - | - |
| Announcement Date | 30/7/21 | 29/7/22 | 28/7/23 | 30/7/24 | 29/7/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.32x | 4.33x | 15.86x | 2.82% | 353B | |
| 17.99x | 2.72x | 12.06x | 3.47% | 134B | |
| 26.49x | 3.82x | 16.06x | 2.26% | 75.27B | |
| 43.66x | 7x | 30.38x | 2.16% | 51.17B | |
| 19.96x | 2.81x | 11.66x | 4.46% | 36.52B | |
| 78.27x | 2.38x | 14.46x | 1.7% | 29.97B | |
| 18.55x | 1.35x | 8.07x | 1.27% | 19.99B | |
| 15.92x | 1.52x | 8.58x | 3.37% | 19.11B | |
| 21.76x | 1.57x | 10.01x | 2.38% | 18.29B | |
| 51.53x | 7.17x | 35.15x | 1.25% | 11.23B | |
| Average | 31.65x | 3.47x | 16.23x | 2.51% | 74.87B | |
| Weighted average by Cap. | 25.70x | 3.84x | 15.68x | 2.81% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
